6% organic sales decline y-o-y Enmac shows progress with good order intake Adj. EBITA down 13-7% for '25e-'26e Q1: High uncertainty is delaying investment decisions Prevas' Q1 report showed that the uncertain market situation continues to impact the ...

6% organic sales decline y-o-y Finnish market is seeing signs of improvement Adj. EBITA down 10-9% for '25e-'26e Q4: Sales -7% and adj. EBITA -23% vs. ABGSCe The challenges from Q3 persisted in Q4, with an organic sales decline of 6% and adj. EBITA of...

1% organic sales decline y-o-y Enmac had negative EBITA in Q3, actions taken Adj. EBITA down 11-7% for '24e-'26e Q3: Sales -10% and adj. EBITA -34% vs. ABGSCe Prevas experienced a challenging Q3, with an organic sales decline of 1% and adj. EBITA of ...

- 3% organic sales growth y-o-y - Lower profitability than we expected - Adj. EBITA down 10-4% for '24-'26e Q2: Sales -2% and adj. EBITA -21% vs. ABGSCe Prevas saw Q2 organic growth increase to 3% y-o-y (from 1% in Q1), although this figure was in line...

Cultural and customer similarities bode well Prevas has received regulatory clearance for its acquisition of Enmac, a Finnish technology consultant with a focus on process and production development. It will be consolidated from 1 July and add roughly...